Furthermore, STAT5 is also progressively inactivated with the progression to metastatic breast cancer due to enhanced regulation by tyrosine phosphatases, such as protein tyrosine phosphatase 1B (PTP1B) [52,85]. Here, STAT5B is linked to breast carcinoma.